Back to Trials
NCT04810624NARecruiting

Relapse Prevention and Changing Habits in Anorexia Nervosa

New York State Psychiatric Institute

Start Date

6/21/2021

Completion Date

6/1/2027

Summary

This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.

Detailed Description

While many approaches to reducing relapse after hospital care have been tried, there is little information about which treatment elements confer benefit. This trial, Relapse Prevention and Changing Habits (REACH+), targets the habitual control of maladaptive behavior to support patients with AN in the 6 months after acute treatment, a time of high vulnerability to relapse. Each component of REACH+ addresses a question that is critical to answer in order to identify and optimize a relapse prevention treatment package that balances efficacy and burden. We will test the acceptability and feasibility of 5 components that together target habits: 1) Behavioral, 2) Cognitive, 3)Motivation, 4) Food Monitoring, and 5) Skill Consolidation. In the Preparation Phase, 10 participants were enrolled, and accessibility and feasibility of the treatment package was examined. The current Optimization Phase includes a finalized treatment manual (including an online platform) and will test each component's contribution to weight maintenance after acute treatment.

Eligibility Criteria

Age Range: 18 years to 60 years

Inclusion Criteria: * Diagnosis of Anorexia Nervosa at hospital admission * Medically Stable * Internet capability with videoconferencing * Weight restored (BMI \> 19 kg/m2) at New York State Psychiatric Institute Exclusion Criteria: * Current substance use or other comorbid disorder requiring specialized treatment * Pregnancy * Imminent risk of suicide * Serious medical illness * Daily psychotropic medication other than antidepressants (medications that are known effect weight are exclusionary, i.e. stimulants, olanzapine, mirtazapine) * Participation in outside psychotherapy or structured treatment program (support groups will be allowed). Individuals who are discharged on medications would need to have a non-study psychiatrist.

Interventions

BEHAVIORAL

Relapse Prevention and Changing Habits (REACH+)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Anorexia Nervosa

Locations

New York State Psychiatric Institute

New York, New York 10032

United States